On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Stocks To Buy Now

Blog


Arotech Corp. (ARTX) Announces $6.7 Million Production Contract

Earlier today, Arotech reported a $6.7 task order from the Space and Naval Warfare Center (SPAWAR) Atlantic. The contract came through its North American Power System Division, which includes UEC Electronics.

The contract awarded is for the manufacture and integration of 12 Communication Emitter Sensing and Attacking System (CESAS) II Platform Integration Kits (PIK). The CESAS is the Marine Corps’ only high-power, ground-mobile electronic attack (EA) asset. The CESAS provides Commanders with the capability to detect, deny, and disrupt the communications of their enemy.

“UEC Electronics has been supporting the SPAWAR Intelligence group for more than 10 years and is pleased with the most recent contract award,” said Mark Matthews, CEO of UEC Electronics. “The DoD is focused on cost savings. Our automated manufacturing processes, coupled with our history of quality products and on-time delivery, make us an ideal provider for this type of mission critical system.”

Arotech received this award following the successful completion of a prototype test of the CESAS II PIK, which performed exceptionally well during U.S. Government-led performance and environmental testing.

Arotech expects to complete this production contract in the next 12 months. The government has an option which, if exercised, will result in a second year of support for the program.

Steven Esses, President and CEO of Arotech, commented, “The award of this contract is a testament to our team and performance of our product. We are excited about the initial opportunity and are optimistic that this award could lead to the procurement of additional units in the future.”

For more information, visit www.arotech.com

From Our Blog

“Urgent Action: PaxMedica Inc. (NASDAQ: PXMD) Addresses Medical Crisis in Malawi”

April 24, 2024

In recent developments, PaxMedica (NASDAQ: PXMD), a renowned biopharmaceutical company specializing in treatments for neurological disorders, has taken swift action to address a pressing medical situation unfolding in Malawi, East Africa. The Ministry of Health (“MOH”) of Malawi has issued a plea for access to IV suramin, a vital medication in combating the life-threatening sleeping […]

Rotate your device 90° to view site.